Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight
RSS SUMMARY · AGGREGATED FROM CNBC
Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity injection Wegovy.
Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity injection Wegovy.
Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity injection Wegovy.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
Business
It’s not just Iran and oil raising inflation. Prices also are reaccelerating in these other areas
CNBC·1h ago·3 min read
US
Analysis: Iran war hangs over Trump’s China trip — and his presidency
CNBC·2h ago·3 min read
Business
Consumer prices rose 3.8% annually in April, the highest since May 2023
CNBC·3h ago·3 min read
US
EBay rejects GameStop’s $56 billion takeover bid, calling it ‘neither credible nor attractive’
CNBC·4h ago·3 min read
Related
On this beat
Health
How physical activity can boost your brain health and reduce dementia risk
CBS NEWS·1h ago·3 min read
Health
Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030
TWSJ·2h ago·3 min read
Health
Parents sue OpenAI over teen’s death after he used ChatGPT to get drug info
CBS NEWS·3h ago·3 min read
Health
Cucumber Sandwich Bites (Grain-Free Options)
WELNESS MAMA·5h ago·3 min read